Literature DB >> 15309878

The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population.

Michael J Connor1, Allan P Weston, Matthew S Mayo, Prateek Sharma.   

Abstract

The purpose of this study was to establish the prevalence of Barrett's esophagus and erosive esophagitis in a group of patients undergoing upper endoscopy for dyspepsia. Computerized endoscopy records were retrospectively evaluated to identify patients who underwent upper endoscopy for dyspepsia. Objective findings were recorded, including the presence of Barrett's esophagus, erosive esophagitis, and peptic ulcer disease. Among 264 patients, Barrett's esophagus was found in 16 (6.1%). The mean length of Barrett's was 2.0 cm, and the majority (81.3%) was short segment. Erosive esophagitis was found in 62 patients (23.%), and peptic ulcer disease was found in 25 patients (9.5%). Approximately 30% of patients undergoing endoscopy for dyspepsia had esophageal lesions. The prevalence of Barrett's in this population was 6%. Based on these results, a trial of acid suppression may benefit a third of patients with dyspepsia. Current screening practices for Barrett's in reflux patients alone may need to be reevaluated.

Entities:  

Mesh:

Year:  2004        PMID: 15309878     DOI: 10.1023/b:ddas.0000034549.55326.67

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  25 in total

1.  Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion.

Authors:  S A McClave; H W Boyce; M R Gottfried
Journal:  Gastrointest Endosc       Date:  1987-12       Impact factor: 9.427

2.  Esophagitis and duodenal ulcer.

Authors:  J P de Moraes-Filho; S Zaterka; H W Pinotti; A Bettarello
Journal:  Digestion       Date:  1974       Impact factor: 3.216

Review 3.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.

Authors:  M Voutilainen; P Sipponen; J P Mecklin; M Juhola; M Färkkilä
Journal:  Digestion       Date:  2000       Impact factor: 3.216

5.  Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.

Authors:  N P Breslin; A B Thomson; R J Bailey; P K Blustein; J Meddings; E Lalor; G M VanRosendaal; M J Verhoef; L R Sutherland
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

6.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

Review 7.  Barrett's esophagus, dysplasia, and adenocarcinoma.

Authors:  R C Haggitt
Journal:  Hum Pathol       Date:  1994-10       Impact factor: 3.466

Review 8.  Geographical differences in the prevalence of dyspepsia.

Authors:  R P Knill-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1991

9.  Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping.

Authors:  J M Hansen; P Bytzer; O B Schaffalitzky De Muckadell
Journal:  Scand J Gastroenterol       Date:  1998-08       Impact factor: 2.423

10.  Histological appearances of oesophagus, antrum and duodenum and their correlation with symptoms in patients with a duodenal ulcer.

Authors:  R J Earlam; J Amerigo; T Kakavoulis; D J Pollock
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

View more
  10 in total

1.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

2.  The global prevalence of Barrett's esophagus: A systematic review of the published literature.

Authors:  Inês Marques de Sá; Pedro Marcos; Prateek Sharma; Mário Dinis-Ribeiro
Journal:  United European Gastroenterol J       Date:  2020-07-06       Impact factor: 4.623

Review 3.  Barrett's esophagus: diagnosis and management.

Authors:  Swathi Eluri; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2017-01-18       Impact factor: 9.427

4.  External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.

Authors:  Theresa H Nguyen; Aaron P Thrift; Gyanprakash A Ketwaroo; Xianglin L Du; Luis Leon Novelo; Rollin George; Daniel G Rosen; Hashem B El-Serag
Journal:  Gastrointest Endosc       Date:  2022-01-06       Impact factor: 10.396

5.  Histopathology of the endoscopic esophagogastric junction in patients with gastroesophageal reflux disease.

Authors:  Claudia Ringhofer; Johannes Lenglinger; Barbara Izay; Katharina Kolarik; Johannes Zacherl; Margit Eisler; Fritz Wrba; Parakrama T Chandrasoma; Enrico P Cosentini; Gerhard Prager; Martin Riegler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Secular trends in patients diagnosed with Barrett's esophagus.

Authors:  Patrick Yachimski; Rebecca A Lee; Angela Tramontano; Norman S Nishioka; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-02       Impact factor: 3.199

Review 7.  Predictors of progression in Barrett's esophagus: current knowledge and future directions.

Authors:  Ganapathy A Prasad; Ajay Bansal; Prateek Sharma; Kenneth K Wang
Journal:  Am J Gastroenterol       Date:  2010-01-26       Impact factor: 10.864

Review 8.  Screening for Barrett's Esophagus.

Authors:  Massimiliano di Pietro; Daniel Chan; Rebecca C Fitzgerald; Kenneth K Wang
Journal:  Gastroenterology       Date:  2015-02-17       Impact factor: 22.682

9.  Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study.

Authors:  Pave Markoš; Iva Brčić; Luka Brčić; Jasminka Jakić-Razumović; Roland Pulanić
Journal:  Croat Med J       Date:  2018-06-30       Impact factor: 1.351

Review 10.  Barrett's esophagus and cancer risk: how research advances can impact clinical practice.

Authors:  Massimiliano di Pietro; Durayd Alzoubaidi; Rebecca C Fitzgerald
Journal:  Gut Liver       Date:  2014-07-01       Impact factor: 4.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.